author-photo

W Rachel Duan

AbbVie

1

Papers

3

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study.

2021 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (3)